儿科呼吸系统反复感染121例治疗分析

目的 探讨儿科呼吸系统反复感染的临床治疗方法.方法 将121例反复呼吸道感染患儿随机分为两组,对照组60例给予常规治疗,实验组61例于常规治疗基础上给予匹多莫德口服治疗,比较两组的临床疗效.结果 实验组、对照组总有效率分别为98.36％、78.33％,实验组总有效率明显高于对照组,两组差异存在统计学意义（P＜0.05）;实验组总病程及退热时间短于对照组,复发频率少于对照组,两组差异存在显著统计学意义（P＜0.01）.结论 匹多莫德口服治疗儿科呼吸系统反复感染,可取得满意的治疗效果,疗效高,病程及退热时间短,复发频率少,值得推广.

Analysis on the Treatment of 121 Cases of Pediatric Respiratory Recurrent Infections

Objective To study the clinical treatment of pediatric respiratory recurrent infections. Methods One hundred and twenty-one children with respiratory recurrent infections were randomly divided into two groups. 60 cases of control group received the conventional treatment, while 61 cases of experimental group received the pidotimod orally on the basis of conventional treatment. The curative effects of two groups were compared. Results The total effective rate of the experimental group was 98.36%, significantly higher than 78.33% of control group （P〈0.05）. The total duration and average antipyretic time of experimental group were shorter than those of control group, and the frequency of recurrence was lower than that of control group （P〈0.01）. Conclusions Pidotimod taken by orally can obtain satisfactory curative effect in the treatment of pediatric respiratory recurrent infections, with higher effect, shorter duration and average antipyretic time, and lower frequency of recurrence, which is worthy of clinical application.